Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "C02" (70)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Methyldopa (Levorotatory) (C02AB01) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Aldomet 250
100 Tablet(s)
20.28
40.25
k.A.
Coated tablets: Methyldopum Anhydricum 250 mg
Future Health Pharma
GmbH
B
FB
G
Clonidine (C02AC01) 3 products
WHO-DDD
DrugBank.ca
IP
Catapresan
5 ampoule(s)
PR
19.10
k.A.
Injection solution: Clonidini Hydrochloridum
CPS Cito Pharma
Services GmbH
B
FB
G
IP
CI
Catapresan
-
T
100 Tablet(s)
PR
PR
k.A.
Tablets: Clonidini Hydrochloridum
CPS Cito Pharma
Services GmbH
B
FB
G
Catapresan Depot
30 Capsule(s)
PR
24.55
k.A.
Delayed release capsules: Clonidini Hydrochloridum
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Guanfacine (C02AC02) 9 products
WHO-DDD
DrugBank.ca
L
IP
CI
Intuniv 1 mg
7
17.74
35.70
10 %
Delayed release tablets: Guanfacinum 1 mg
Takeda Pharma AG
● 
B / SL
FB
G
L
IP
CI
Intuniv 1 mg
28
70.92
93.55
10 %
Delayed release tablets: Guanfacinum 1 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 2 mg
7
18.10
36.10
10 %
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 2 mg
28
72.41
95.15
10 %
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 3 mg
28
75.76
98.80
10 %
Delayed release tablets: Guanfacinum 3 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 4 mg
28
81.66
105.25
10 %
Delayed release tablets: Guanfacinum 4 mg
Takeda Pharma AG
B / SL
FB
G
IP
Intuniv 2 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B
FB
G
IP
Intuniv 3 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 3 mg
Takeda Pharma AG
B
FB
G
IP
Intuniv 4 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 4 mg
Takeda Pharma AG
B
FB
G
Moxonidine (C02AC05) 6 products
WHO-DDD
DrugBank.ca
L
IP
CI
Physiotens mite 0,2 mg
28 Tablet(s)
6.91
16.75
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Physiotens mite 0,2 mg
98 Tablet(s)
20.81
39.05
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Physiotens 0,3 mg
28 Tablet(s)
9.07
26.30
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Physiotens 0,3 mg
98 Tablet(s)
29.42
48.40
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Physiotens forte 0,4 mg
28 Tablet(s)
10.40
27.75
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Physiotens forte 0,4 mg
98 Tablet(s)
34.01
53.40
10 %
Coated tablets: Moxonidinum
Viatris Pharma GmbH
B / SL
FB
G
Doxazosin (C02CA04) 7 products
WHO-DDD
DrugBank.ca
L
IP
CI
Cardura CR 4 mg
30 Tablet(s)
10.62
27.85
10 %
Coated tablets: Doxazosinum 4 mg
Viatris Pharma GmbH
B / SL / SO
FB
G
L
IP
CI
Cardura CR 4 mg
100 Tablet(s)
32.97
52.05
10 %
Coated tablets: Doxazosinum 4 mg
Viatris Pharma GmbH
B / SL / SO
FB
G
L
IP
CI
Cardura CR 8 mg
100 Tablet(s)
48.28
68.55
10 %
Coated tablets: Doxazosinum 8 mg
Viatris Pharma GmbH
B / SL / SO
FB
G
L
IP
CI
Doxazosin retard Zentiva 4 mg
28
8.92
26.10
10 %
Coated tablets: Doxazosinum 4 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 4 mg
98
29.08
48.05
10 %
Coated tablets: Doxazosinum 4 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 8 mg
28
11.58
29.00
10 %
Coated tablets: Doxazosinum 8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Doxazosin retard Zentiva 8 mg
98
42.59
62.75
10 %
Coated tablets: Doxazosinum 8 mg
Helvepharm AG
B / SL / SG
FB
G
Urapidil (C02CA06) 3 products
WHO-DDD
IP
Ebrantil 50 mg
5 1 ampoule(s) à 10 ml
PR
101.00
k.A.
Injection solution: Urapidilum 50mg / 10ml
Cheplapharm Schweiz
GmbH
B
FB
G
IP
Urapidil Stragen i.v. 25 mg
5 x 5 ml
PR
PR
k.A.
Injection solution: Urapidilum 25mg / 5ml
Stragen Pharma SA
B
FB
G
IP
Urapidil Stragen i.v. 50 mg
5 x 10 ml
PR
PR
k.A.
Injection solution: Urapidilum 50mg / 10ml
Stragen Pharma SA
B
FB
G
Nitroprusside (C02DD01) 1 products
WHO-DDD
DrugBank.ca
IP
Nipruss 60 mg
5
PR
PR
k.A.
Lyophilisate: Natrii Nitroprussias Dihydricus 60 mg
Ospedalia AG
A
FB
G
Antihypertensives for Pulmonary Arterial Hypertension (C02KX) 4 products
WHO-DDD
IP
Winrevair 45 mg
PR
PR
k.A.
Dry substance: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 45 mg
2
PR
PR
k.A.
Dry substance: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 60 mg
PR
PR
k.A.
Dry substance: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
Winrevair 60 mg
2
PR
PR
k.A.
Dry substance: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B
FB
G
Bosentan (C02KX01) 9 products
WHO-DDD
DrugBank.ca
IP
CI
Tracleer 62,5 mg
56 Tablet(s)
922.05
1013.50
10 %
Coated tablets: Bosentanum 62.5 mg
Janssen-Cilag AG
● 
B / SL / SO
FB
G
IP
CI
Tracleer 62,5 mg
56
922.05
1013.50
10 %
Coated tablets: Bosentanum 62.5 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Tracleer 125 mg
56 Tablet(s)
922.05
1013.50
10 %
Coated tablets: Bosentanum 125 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Tracleer 125 mg
56
922.05
1013.50
10 %
Coated tablets: Bosentanum 125 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
56
829.85
918.95
10 %
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Bosentan-Mepha 125 mg
56
829.85
918.95
10 %
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Tracleer
56 Tablet(s)
PR
PR
k.A.
Dispersible Tablets: Bosentanum 32 mg
Janssen-Cilag AG
B
FB
G
IP
CI
Bosentan-Mepha 62.5 mg
14
PR
PR
k.A.
Coated tablets: Bosentanum 62.5 mg
Mepha Pharma AG
B
FB
G
IP
CI
Bosentan-Mepha 125 mg
14
PR
PR
k.A.
Coated tablets: Bosentanum 125 mg
Mepha Pharma AG
B
FB
G
Ambrisentan (C02KX02) 10 products
WHO-DDD
DrugBank.ca
L
IP
CI
Volibris 5 mg
30 Tablet(s)
1089.60
1195.35
10 %
Coated tablets: Ambrisentanum 5 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
L
IP
CI
Volibris 10 mg
30 Tablet(s)
1089.60
1195.35
10 %
Coated tablets: Ambrisentanum 10 mg
GlaxoSmithKline AG
B / SL / SO
FB
G
L
IP
CI
Ambrisentan Devatis 5 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B / SL / SG
FB
G
L
IP
Ambrisentan Devatis 10 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Ambrisentan OrPha 5 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 5 mg
OrPha Swiss GmbH
B / SL / SG
FB
G
L
IP
Ambrisentan OrPha 10 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 10 mg
OrPha Swiss GmbH
B / SL / SG
FB
G
L
IP
CI
Ambrisentan-Mepha 5 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ambrisentan-Mepha 10 mg
30
990.57
1093.70
10 %
Coated tablets: Ambrisentanum 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Ambrisentan Devatis 5 mg
10
PR
PR
k.A.
Coated tablets: Ambrisentanum 5 mg
Devatis AG
B
FB
G
IP
Ambrisentan Devatis 10 mg
10
PR
PR
k.A.
Coated tablets: Ambrisentanum 10 mg
Devatis AG
B
FB
G
Macitentan (C02KX04) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Opsumit 10 mg
30 Tablet(s)
2800.97
3062.65
10 %
Coated tablets: Macitentanum 10 mg
Actelion
Pharmaceuticals Ltd
B / SL
FB
G
Riociguat (C02KX05) 10 products
WHO-DDD
DrugBank.ca
L
IP
CI
PP
Adempas 0.5 mg
42 Tablet(s)
1288.67
1417.90
10 %
Coated tablets: Riociguatum
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 1 mg
42 Tablet(s)
1288.67
1417.90
10 %
Coated tablets: Riociguatum 1 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 1.5 mg
42 Tablet(s)
1288.67
1417.90
10 %
Coated tablets: Riociguatum 1.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 1.5 mg
84 Tablet(s)
2577.34
2819.45
10 %
Coated tablets: Riociguatum 1.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 2 mg
42 Tablet(s)
1288.67
1417.90
10 %
Coated tablets: Riociguatum 2 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 2 mg
84 Tablet(s)
2577.34
2819.45
10 %
Coated tablets: Riociguatum 2 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 2.5 mg
42 Tablet(s)
1288.67
1417.90
10 %
Coated tablets: Riociguatum 2.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Adempas 2.5 mg
84 Tablet(s)
2577.34
2819.45
10 %
Coated tablets: Riociguatum 2.5 mg
Bayer (Schweiz) AG
B / SL
FB
G
IP
CI
PP
Adempas 0.5 mg
84 Tablet(s)
PR
PR
k.A.
Coated tablets: Riociguatum
Bayer (Schweiz) AG
B
FB
G
IP
CI
PP
Adempas 1 mg
84 Tablet(s)
2577.34
2819.45
k.A.
Coated tablets: Riociguatum 1 mg
Bayer (Schweiz) AG
B
FB
G
Sotatercept (C02KX06) 4 products
WHO-DDD
L
IP
CI
Winrevair 45 mg
5956.94
6419.60
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
CI
Winrevair 45 mg
2
11913.87
12531.45
10 %
Lyophilisate and solvent: Sotaterceptum 45 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
Winrevair 60 mg
7942.58
8456.90
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
Winrevair 60 mg
2
15885.16
16605.95
10 %
Lyophilisate and solvent: Sotaterceptum 60 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
Macitentan and Tadalafil (C02KX54) 1 products
WHO-DDD
L
IP
CI
Yuvanci 10 mg/40 mg
30
2736.57
2992.60
10 %
Coated tablets: 2 Active Agents
Janssen-Cilag AG
B / SL
FB
G
(C02KZ) 1 products
WHO-DDD
CI
H
Co-Hypert
100 ml
PR
27.20
k.A.
Tropfen zum Einnehmen: 7 Active Agents
ebi-pharm ag
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home